ZEPP - Zepp Health Corpora... Stock Analysis | Stock Taper
Logo
Zepp Health Corporation

ZEPP

Zepp Health Corporation NYSE
$19.28 -12.76% (-2.82)

Market Cap $276.14 M
52w High $61.85
52w Low $2.13
Dividend Yield 0.84%
Frequency Special
P/E -4.82
Volume 78.75K
Outstanding Shares 14.32M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $539.56M $212.2M $-11.5M -2.13% $-0.73 $6.44M
Q2-2025 $427.07M $198.35M $-55.64M -13.03% $-3.5 $-36.2M
Q1-2025 $279.89M $237.76M $-143.37M -51.23% $-9.32 $-130.11M
Q4-2024 $433.03M $224.49M $-268.55M -62.02% $-16.74 $-134.28M
Q3-2024 $297.67M $208.77M $-92.89M -31.21% $-5.76 $-80.65M

What's going well?

Sales jumped 26% and losses shrank sharply, showing the company can scale up and control costs. Gross margins improved, and efficiency is trending better as expenses grow slower than revenue.

What's concerning?

The company is still losing money and interest costs are rising. Overhead costs are up, and profitability remains out of reach for now.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $446.69M $4.17B $2.56B $1.61B
Q2-2025 $690.15M $3.93B $2.32B $1.61B
Q1-2025 $761.42M $3.77B $2.08B $1.69B
Q4-2024 $815.51M $3.86B $2.01B $1.84B
Q3-2024 $929.8M $4.13B $1.92B $2.2B

What's financially strong about this company?

Debt was paid down significantly this quarter, and the company still has over $1 billion in liquid assets. Most assets are tangible, and equity is solidly positive.

What are the financial risks or weaknesses?

Cash reserves fell sharply, and the company is delaying payments to suppliers, which could signal cash flow stress. Retained earnings are negative, showing little historical profit.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-11.5M $0 $0 $0 $0 $0
Q2-2025 $-55.64M $0 $0 $0 $-61M $0
Q1-2025 $-143.37M $0 $0 $0 $-50.1M $0
Q4-2024 $-269.16M $0 $0 $0 $0 $0
Q3-2024 $-92.89M $0 $0 $0 $-6.53M $0

Q3 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Zepp Health Corporation's financial evolution and strategic trajectory over the past five years.

+ Strengths

Zepp’s core strengths include its vertically integrated technology stack, differentiated focus on long battery life and AI-driven health insights, and a growing ecosystem that now spans smartwatches, fitness wearables, hearing aids, and wellness services. Historically, it has demonstrated the ability to earn solid gross profits and to generate strong cash flow in more favorable years. The balance sheet still shows positive equity and a meaningful asset base, which provides some buffer as the company works through a difficult period.

! Risks

The main risks are financial and competitive. Revenue has fallen sharply, losses have deepened, and cash flows have turned mostly negative, while liquidity has weakened and net debt has risen. If these trends persist, they could constrain the company’s ability to invest sufficiently in R&D, marketing, and ecosystem expansion, just as competition in wearables and digital health remains fierce. There is also execution risk around new product categories and AI features—if these do not gain traction, the payoff from current innovation efforts may be limited.

Outlook

The outlook is highly dependent on Zepp’s ability to stabilize its top line and restore at least break-even economics while preserving enough R&D and marketing firepower to maintain differentiation. Its technology platform and ecosystem give it tools to pursue a turnaround, especially if it can deepen engagement with health-focused users and carve out defensible niches. At the same time, the current financial trajectory is unfavorable, leaving the near- to medium-term picture cautious and uncertain until clearer evidence of revenue stabilization, margin improvement, and more consistent positive cash generation emerges.